APO Research
Talk to an analyst

APO RESEARCH · REPORT

Tildrakizumab

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Tildrakizumab Market Analysis and Forecast 2026-2032

20 December 2025194 pages

Choose your research edition.

Industry ResearchTildrakizumab Industry Research Report 2026111 pages · $2,950 USDIndustry Growth & TrendsGlobal Tildrakizumab Industry Growth and Trends Forecast to 203273 pages · $3,450 USDMarket StructureGlobal Tildrakizumab Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032170 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Tildrakizumab Market Outlook and Growth Opportunities 2026199 pages · $4,250 USDMarket Analysis & ForecastGlobal Tildrakizumab Market Analysis and Forecast 2026-2032194 pages · $4,950 USD

Market perspective

The global Tildrakizumab market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Tildrakizumab is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Tildrakizumab is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Tildrakizumab is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Tildrakizumab is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Tildrakizumab include Sun Pharma. etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Tildrakizumab, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Tildrakizumab, also provides the sales of main regions and countries. Of the upcoming market potential for Tildrakizumab, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Tildrakizumab sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Tildrakizumab market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Tildrakizumab sales, projected growth trends, production technology, application and end-user industry.

Tildrakizumab Segment by Company

Sun Pharma

Tildrakizumab Segment by Type

18MIU /Vial

25MIU /Vial

Tildrakizumab Segment by Application

Hospital

Drug Store

Tildrakizumab Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Tildrakizumab market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Tildrakizumab and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Tildrakizumab.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Tildrakizumab in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Tildrakizumab manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Tildrakizumab sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Tildrakizumab Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. 18MIU /Vial Major Manufacturers Table 3. 25MIU /Vial Major Manufacturers Table 4. Global Tildrakizumab Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Hospital Major Manufacturers Table 6. Drug Store Major Manufacturers Table 7. Tildrakizumab Industry Trends Table 8. Tildrakizumab Industry Drivers Table 9. Tildrakizumab Industry Opportunities and Challenges Table 10. Tildrakizumab Industry Restraints Table 11. Global Tildrakizumab Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 12. Global Tildrakizumab Revenue by Region (2021-2026) & (US$ Million) Table 13. Global Tildrakizumab Revenue by Region (2027-2032) & (US$ Million) Table 14. Global Tildrakizumab Revenue Market Share by Region (2021-2026) Table 15. Global Tildrakizumab Revenue Market Share by Region (2027-2032) Table 16. Global Tildrakizumab Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (W Units) Table 17. Global Tildrakizumab Sales by Region (2021-2026) & (W Units) Table 18. Global Tildrakizumab Sales by Region (2027-2032) & (W Units) Table 19. Global Tildrakizumab Sales Market Share by Region (2021-2026) Table 20. Global Tildrakizumab Sales Market Share by Region (2027-2032) Table 21. Global Tildrakizumab Revenue by Manufacturers (US$ Million) & (2021-2026) Table 22. Global Tildrakizumab Revenue Market Share by Manufacturers (2021-2026) Table 23. Global Tildrakizumab Sales by Manufacturers (US$ Million) & (2021-2026) Table 24. Global Tildrakizumab Sales Market Share by Manufacturers (2021-2026) Table 25. Global Tildrakizumab Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 26. Global Tildrakizumab Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 27. Global Tildrakizumab Key Manufacturers Manufacturing Sites & Headquarters Table 28. Global Tildrakizumab Manufacturers, Product Type & Application Table 29. Global Tildrakizumab Manufacturers' Establishment Date Table 30. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 31. Global Tildrakizumab by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 32. Global Tildrakizumab Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 33. Global Tildrakizumab Revenue by Type (2021-2026) & (US$ Million) Table 34. Global Tildrakizumab Revenue by Type (2027-2032) & (US$ Million) Table 35. Global Tildrakizumab Revenue Market Share by Type (2021-2026) Table 36. Global Tildrakizumab Revenue Market Share by Type (2027-2032) Table 37. Global Tildrakizumab Sales by Type 2021 VS 2025 VS 2032 (W Units) Table 38. Global Tildrakizumab Sales by Type (2021-2026) & (W Units) Table 39. Global Tildrakizumab Sales by Type (2027-2032) & (W Units) Table 40. Global Tildrakizumab Sales Market Share by Type (2021-2026) Table 41. Global Tildrakizumab Sales Market Share by Type (2027-2032) Table 42. Global Tildrakizumab Price by Type (2021-2026) & (US$/Unit) Table 43. Global Tildrakizumab Price by Type (2027-2032) & (US$/Unit) Table 44. Global Tildrakizumab Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 45. Global Tildrakizumab Revenue by Application (2021-2026) & (US$ Million) Table 46. Global Tildrakizumab Revenue by Application (2027-2032) & (US$ Million) Table 47. Global Tildrakizumab Revenue Market Share by Application (2021-2026) Table 48. Global Tildrakizumab Revenue Market Share by Application (2027-2032) Table 49. Global Tildrakizumab Sales by Application 2021 VS 2025 VS 2032 (W Units) Table 50. Global Tildrakizumab Sales by Application (2021-2026) & (W Units) Table 51. Global Tildrakizumab Sales by Application (2027-2032) & (W Units) Table 52. Global Tildrakizumab Sales Market Share by Application (2021-2026) Table 53. Global Tildrakizumab Sales Market Share by Application (2027-2032) Table 54. Global Tildrakizumab Price by Application (2021-2026) & (US$/Unit) Table 55. Global Tildrakizumab Price by Application (2027-2032) & (US$/Unit) Table 56. Sun Pharma Company Information Table 57. Sun Pharma Business Overview Table 58. Sun Pharma Tildrakizumab Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 59. Sun Pharma Tildrakizumab Product Portfolio Table 60. Sun Pharma Recent Development Table 61. North America Tildrakizumab Revenue by Type (2021-2026) & (US$ Million) Table 62. North America Tildrakizumab Revenue by Type (2027-2032) & (US$ Million) Table 63. North America Tildrakizumab Sales by Type (2021-2026) & (W Units) Table 64. North America Tildrakizumab Sales by Type (2027-2032) & (W Units) Table 65. North America Tildrakizumab Sales Price by Type (2021-2026) & (US$/Unit) Table 66. North America Tildrakizumab Sales Price by Type (2027-2032) & (US$/Unit) Table 67. North America Tildrakizumab Revenue by Application (2021-2026) & (US$ Million) Table 68. North America Tildrakizumab Revenue by Application (2027-2032) & (US$ Million) Table 69. North America Tildrakizumab Sales by Application (2021-2026) & (W Units) Table 70. North America Tildrakizumab Sales by Application (2027-2032) & (W Units) Table 71. North America Tildrakizumab Sales Price by Application (2021-2026) & (US$/Unit) Table 72. North America Tildrakizumab Sales Price by Application (2027-2032) & (US$/Unit) Table 73. North America Tildrakizumab Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 74. North America Tildrakizumab Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 75. North America Tildrakizumab Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 76. North America Tildrakizumab Sales by Country (2021 VS 2025 VS 2032) & (W Units) Table 77. North America Tildrakizumab Sales by Country (2021-2026) & (W Units) Table 78. North America Tildrakizumab Sales by Country (2027-2032) & (W Units) Table 79. North America Tildrakizumab Sales Price by Country (2021-2026) & (US$/Unit) Table 80. North America Tildrakizumab Sales Price by Country (2027-2032) & (US$/Unit) Table 81. United States Tildrakizumab Revenue (2021-2032) & (US$ Million) Table 82. Canada Tildrakizumab Revenue (2021-2032) & (US$ Million) Table 83. Europe Tildrakizumab Revenue by Type (2021-2026) & (US$ Million) Table 84. Europe Tildrakizumab Revenue by Type (2027-2032) & (US$ Million) Table 85. Europe Tildrakizumab Sales by Type (2021-2026) & (W Units) Table 86. Europe Tildrakizumab Sales by Type (2027-2032) & (W Units) Table 87. Europe Tildrakizumab Sales Price by Type (2021-2026) & (US$/Unit) Table 88. Europe Tildrakizumab Sales Price by Type (2027-2032) & (US$/Unit) Table 89. Europe Tildrakizumab Revenue by Application (2021-2026) & (US$ Million) Table 90. Europe Tildrakizumab Revenue by Application (2027-2032) & (US$ Million) Table 91. Europe Tildrakizumab Sales by Application (2021-2026) & (W Units) Table 92. Europe Tildrakizumab Sales by Application (2027-2032) & (W Units) Table 93. Europe Tildrakizumab Sales Price by Application (2021-2026) & (US$/Unit) Table 94. Europe Tildrakizumab Sales Price by Application (2027-2032) & (US$/Unit) Table 95. Europe Tildrakizumab Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 96. Europe Tildrakizumab Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 97. Europe Tildrakizumab Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 98. Europe Tildrakizumab Sales by Country (2021 VS 2025 VS 2032) & (W Units) Table 99. Europe Tildrakizumab Sales by Country (2021-2026) & (W Units) Table 100. Europe Tildrakizumab Sales by Country (2027-2032) & (W Units) Table 101. Europe Tildrakizumab Sales Price by Country (2021-2026) & (US$/Unit) Table 102. Europe Tildrakizumab Sales Price by Country (2027-2032) & (US$/Unit) Table 103. Germany Tildrakizumab Revenue (2021-2032) & (US$ Million) Table 104. France Tildrakizumab Revenue (2021-2032) & (US$ Million) Table 105. U.K. Tildrakizumab Revenue (2021-2032) & (US$ Million) Table 106. Italy Tildrakizumab Revenue (2021-2032) & (US$ Million) Table 107. Netherlands Tildrakizumab Revenue (2021-2032) & (US$ Million) Table 108. China Tildrakizumab Revenue by Type (2021-2026) & (US$ Million) Table 109. China Tildrakizumab Revenue by Type (2027-2032) & (US$ Million) Table 110. China Tildrakizumab Sales by Type (2021-2026) & (W Units) Table 111. China Tildrakizumab Sales by Type (2027-2032) & (W Units) Table 112. China Tildrakizumab Sales Price by Type (2021-2026) & (US$/Unit) Table 113. China Tildrakizumab Sales Price by Type (2027-2032) & (US$/Unit) Table 114. China Tildrakizumab Revenue by Application (2021-2026) & (US$ Million) Table 115. China Tildrakizumab Revenue by Application (2027-2032) & (US$ Million) Table 116. China Tildrakizumab Sales by Application (2021-2026) & (W Units) Table 117. China Tildrakizumab Sales by Application (2027-2032) & (W Units) Table 118. China Tildrakizumab Sales Price by Application (2021-2026) & (US$/Unit) Table 119. China Tildrakizumab Sales Price by Application (2027-2032) & (US$/Unit) Table 120. Asia Tildrakizumab Revenue by Type (2021-2026) & (US$ Million) Table 121. Asia Tildrakizumab Revenue by Type (2027-2032) & (US$ Million) Table 122. Asia Tildrakizumab Sales by Type (2021-2026) & (W Units) Table 123. Asia Tildrakizumab Sales by Type (2027-2032) & (W Units) Table 124. Asia Tildrakizumab Sales Price by Type (2021-2026) & (US$/Unit) Table 125. Asia Tildrakizumab Sales Price by Type (2027-2032) & (US$/Unit) Table 126. Asia Tildrakizumab Revenue by Application (2021-2026) & (US$ Million) Table 127. Asia Tildrakizumab Revenue by Application (2027-2032) & (US$ Million) Table 128. Asia Tildrakizumab Sales by Application (2021-2026) & (W Units) Table 129. Asia Tildrakizumab Sales by Application (2027-2032) & (W Units) Table 130. Asia Tildrakizumab Sales Price by Application (2021-2026) & (US$/Unit) Table 131. Asia Tildrakizumab Sales Price by Application (2027-2032) & (US$/Unit) Table 132. Asia Tildrakizumab Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 133. Asia Tildrakizumab Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 134. Asia Tildrakizumab Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 135. Asia Tildrakizumab Sales by Country (2021 VS 2025 VS 2032) & (W Units) Table 136. Asia Tildrakizumab Sales by Country (2021-2026) & (W Units) Table 137. Asia Tildrakizumab Sales by Country (2027-2032) & (W Units) Table 138. Asia Tildrakizumab Sales Price by Country (2021-2026) & (US$/Unit) Table 139. Asia Tildrakizumab Sales Price by Country (2027-2032) & (US$/Unit) Table 140. Japan Tildrakizumab Revenue (2021-2032) & (US$ Million) Table 141. South Korea Tildrakizumab Revenue (2021-2032) & (US$ Million) Table 142. India Tildrakizumab Revenue (2021-2032) & (US$ Million) Table 143. Australia Tildrakizumab Revenue (2021-2032) & (US$ Million) Table 144. China Taiwan Tildrakizumab Revenue (2021-2032) & (US$ Million) Table 145. Southeast Asia Tildrakizumab Revenue (2021-2032) & (US$ Million) Table 146. SAMEA Tildrakizumab Revenue by Type (2021-2026) & (US$ Million) Table 147. SAMEA Tildrakizumab Revenue by Type (2027-2032) & (US$ Million) Table 148. SAMEA Tildrakizumab Sales by Type (2021-2026) & (W Units) Table 149. SAMEA Tildrakizumab Sales by Type (2027-2032) & (W Units) Table 150. SAMEA Tildrakizumab Sales Price by Type (2021-2026) & (US$/Unit) Table 151. SAMEA Tildrakizumab Sales Price by Type (2027-2032) & (US$/Unit) Table 152. SAMEA Tildrakizumab Revenue by Application (2021-2026) & (US$ Million) Table 153. SAMEA Tildrakizumab Revenue by Application (2027-2032) & (US$ Million) Table 154. SAMEA Tildrakizumab Sales by Application (2021-2026) & (W Units) Table 155. SAMEA Tildrakizumab Sales by Application (2027-2032) & (W Units) Table 156. SAMEA Tildrakizumab Sales Price by Application (2021-2026) & (US$/Unit) Table 157. SAMEA Tildrakizumab Sales Price by Application (2027-2032) & (US$/Unit) Table 158. SAMEA Tildrakizumab Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 159. SAMEA Tildrakizumab Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 160. SAMEA Tildrakizumab Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 161. SAMEA Tildrakizumab Sales by Country (2021 VS 2025 VS 2032) & (W Units) Table 162. SAMEA Tildrakizumab Sales by Country (2021-2026) & (W Units) Table 163. SAMEA Tildrakizumab Sales by Country (2027-2032) & (W Units) Table 164. SAMEA Tildrakizumab Sales Price by Country (2021-2026) & (US$/Unit) Table 165. SAMEA Tildrakizumab Sales Price by Country (2027-2032) & (US$/Unit) Table 166. Brazil Tildrakizumab Revenue (2021-2032) & (US$ Million) Table 167. Argentina Tildrakizumab Revenue (2021-2032) & (US$ Million) Table 168. Chile Tildrakizumab Revenue (2021-2032) & (US$ Million) Table 169. Colombia Tildrakizumab Revenue (2021-2032) & (US$ Million) Table 170. Peru Tildrakizumab Revenue (2021-2032) & (US$ Million) Table 171. Saudi Arabia Tildrakizumab Revenue (2021-2032) & (US$ Million) Table 172. Israel Tildrakizumab Revenue (2021-2032) & (US$ Million) Table 173. UAE Tildrakizumab Revenue (2021-2032) & (US$ Million) Table 174. Turkey Tildrakizumab Revenue (2021-2032) & (US$ Million) Table 175. Iran Tildrakizumab Revenue (2021-2032) & (US$ Million) Table 176. Egypt Tildrakizumab Revenue (2021-2032) & (US$ Million) Table 177. Key Raw Materials Table 178. Raw Materials Key Suppliers Table 179. Tildrakizumab Distributors List Table 180. Tildrakizumab Customers List Table 181. Research Programs/Design for This Report Table 182. Authors List of This Report Table 183. Secondary Sources Table 184. Primary Sources List of Figures Figure 1. Tildrakizumab Image Figure 2. Global Tildrakizumab Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Tildrakizumab Market Size Share 2021 VS 2025 VS 2032 Figure 4. 18MIU /Vial Image Figure 5. 25MIU /Vial Image Figure 6. Global Tildrakizumab Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Tildrakizumab Market Size Share 2021 VS 2025 VS 2032 Figure 8. Hospital Image Figure 9. Drug Store Image Figure 10. Global Tildrakizumab Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 11. Global Tildrakizumab Revenue (2021-2032) & (US$ Million) Figure 12. Global Tildrakizumab Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 13. Global Tildrakizumab Revenue Market Share by Region: 2025 Versus 2032 Figure 14. Global Tildrakizumab Revenue Market Share by Region (2021-2032) Figure 15. Global Tildrakizumab Sales (2021-2032) & (W Units) Figure 16. Global Tildrakizumab Sales by Region: 2021 VS 2025 VS 2032 (W Units) Figure 17. Global Tildrakizumab Sales Market Share by Region (2021-2032) Figure 18. US & Canada & Mexico Tildrakizumab Sales YoY (2021-2032) & (W Units) Figure 19. Europe Tildrakizumab Sales YoY (2021-2032) & (W Units) Figure 20. China Tildrakizumab Sales YoY (2021-2032) & (W Units) Figure 21. Asia (Excluding China) Tildrakizumab Sales YoY (2021-2032) & (W Units) Figure 22. South America, Middle East and Africa Tildrakizumab Sales YoY (2021-2032) & (W Units) Figure 23. Global Tildrakizumab Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 24. Global Tildrakizumab Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 25. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 26. Global Tildrakizumab Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 27. Global Tildrakizumab Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 28. Global Tildrakizumab Revenue Market Share by Type (2021-2032) Figure 29. Global Tildrakizumab Sales by Type (2021 VS 2025 VS 2032) & (W Units) Figure 30. Global Tildrakizumab Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 31. Global Tildrakizumab Sales Market Share by Type (2021-2032) Figure 32. Global Tildrakizumab Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 33. Global Tildrakizumab Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 34. Global Tildrakizumab Revenue Market Share by Application (2021-2032) Figure 35. Global Tildrakizumab Sales by Application (2021 VS 2025 VS 2032) & (W Units) Figure 36. Global Tildrakizumab Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 37. Global Tildrakizumab Sales Market Share by Application (2021-2032) Figure 38. North America Tildrakizumab Revenue Share by Type (2021-2032) Figure 39. North America Tildrakizumab Sales Share by Type (2021-2032) Figure 40. North America Tildrakizumab Revenue Share by Application (2021-2032) Figure 41. North America Tildrakizumab Sales Share by Application (2021-2032) Figure 42. North America Tildrakizumab Revenue Share by Country (2021-2032) Figure 43. North America Tildrakizumab Sales Share by Country (2021-2032) Figure 44. Europe Tildrakizumab Revenue Share by Type (2021-2032) Figure 45. Europe Tildrakizumab Sales Share by Type (2021-2032) Figure 46. Europe Tildrakizumab Revenue Share by Application (2021-2032) Figure 47. Europe Tildrakizumab Sales Share by Application (2021-2032) Figure 48. Europe Tildrakizumab Revenue Share by Country (2021-2032) Figure 49. Europe Tildrakizumab Sales Share by Country (2021-2032) Figure 50. China Tildrakizumab Revenue Share by Type (2021-2032) Figure 51. China Tildrakizumab Sales Share by Type (2021-2032) Figure 52. China Tildrakizumab Revenue Share by Application (2021-2032) Figure 53. China Tildrakizumab Sales Share by Application (2021-2032) Figure 54. Asia Tildrakizumab Revenue Share by Type (2021-2032) Figure 55. Asia Tildrakizumab Sales Share by Type (2021-2032) Figure 56. Asia Tildrakizumab Revenue Share by Application (2021-2032) Figure 57. Asia Tildrakizumab Sales Share by Application (2021-2032) Figure 58. Asia Tildrakizumab Revenue Share by Country (2021-2032) Figure 59. Asia Tildrakizumab Sales Share by Country (2021-2032) Figure 60. SAMEA Tildrakizumab Revenue Share by Type (2021-2032) Figure 61. SAMEA Tildrakizumab Sales Share by Type (2021-2032) Figure 62. SAMEA Tildrakizumab Revenue Share by Application (2021-2032) Figure 63. SAMEA Tildrakizumab Sales Share by Application (2021-2032) Figure 64. SAMEA Tildrakizumab Revenue Share by Country (2021-2032) Figure 65. SAMEA Tildrakizumab Sales Share by Country (2021-2032) Figure 66. Tildrakizumab Value Chain Figure 67. Manufacturing Cost Structure Figure 68. Tildrakizumab Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • 18MIU /Vial
  • 25MIU /Vial
Applications
  • Hospital
  • Drug Store
Companies covered
  • Sun Pharma

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Tildrakizumab Market by Type
  3. 1.2.1 Global Tildrakizumab Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 18MIU /Vial
  5. 1.2.3 25MIU /Vial
  6. 1.3 Tildrakizumab Market by Application
  7. 1.3.1 Global Tildrakizumab Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Hospital
  9. 1.3.3 Drug Store
  10. 1.4 Assumptions and Limitations
  11. 1.5 Study Goals and Objectives
2 Tildrakizumab Market Dynamics
  1. 2.1 Tildrakizumab Industry Trends
  2. 2.2 Tildrakizumab Industry Drivers
  3. 2.3 Tildrakizumab Industry Opportunities and Challenges
  4. 2.4 Tildrakizumab Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Tildrakizumab Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Tildrakizumab Revenue by Region
  3. 3.2.1 Global Tildrakizumab Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Tildrakizumab Revenue by Region (2021-2026)
  5. 3.2.3 Global Tildrakizumab Revenue by Region (2027-2032)
  6. 3.2.4 Global Tildrakizumab Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Tildrakizumab Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Tildrakizumab Sales by Region
  9. 3.4.1 Global Tildrakizumab Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Tildrakizumab Sales by Region (2021-2026)
  11. 3.4.3 Global Tildrakizumab Sales by Region (2027-2032)
  12. 3.4.4 Global Tildrakizumab Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Tildrakizumab Revenue by Manufacturers
  2. 4.1.1 Global Tildrakizumab Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Tildrakizumab Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Tildrakizumab Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Tildrakizumab Sales by Manufacturers
  6. 4.2.1 Global Tildrakizumab Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Tildrakizumab Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Tildrakizumab Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Tildrakizumab Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Tildrakizumab Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Tildrakizumab Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Tildrakizumab Manufacturers, Product Type & Application
  13. 4.7 Global Tildrakizumab Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Tildrakizumab Market CR5 and HHI
  16. 4.8.2 2025 Tildrakizumab Tier 1, Tier 2, and Tier 3
5 Tildrakizumab Market by Type
  1. 5.1 Global Tildrakizumab Revenue by Type
  2. 5.1.1 Global Tildrakizumab Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Tildrakizumab Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Tildrakizumab Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Tildrakizumab Sales by Type
  6. 5.2.1 Global Tildrakizumab Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Tildrakizumab Sales by Type (2021-2032) & (W Units)
  8. 5.2.3 Global Tildrakizumab Sales Market Share by Type (2021-2032)
  9. 5.3 Global Tildrakizumab Price by Type
6 Tildrakizumab Market by Application
  1. 6.1 Global Tildrakizumab Revenue by Application
  2. 6.1.1 Global Tildrakizumab Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Tildrakizumab Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Tildrakizumab Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Tildrakizumab Sales by Application
  6. 6.2.1 Global Tildrakizumab Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Tildrakizumab Sales by Application (2021-2032) & (W Units)
  8. 6.2.3 Global Tildrakizumab Sales Market Share by Application (2021-2032)
  9. 6.3 Global Tildrakizumab Price by Application
7 Company Profiles
  1. 7.1 Sun Pharma
  2. 7.1.1 Sun Pharma Company Information
  3. 7.1.2 Sun Pharma Business Overview
  4. 7.1.3 Sun Pharma Tildrakizumab Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Sun Pharma Tildrakizumab Product Portfolio
  6. 7.1.5 Sun Pharma Recent Developments
8 North America
  1. 8.1 North America Tildrakizumab Market Size by Type
  2. 8.1.1 North America Tildrakizumab Revenue by Type (2021-2032)
  3. 8.1.2 North America Tildrakizumab Sales by Type (2021-2032)
  4. 8.1.3 North America Tildrakizumab Price by Type (2021-2032)
  5. 8.2 North America Tildrakizumab Market Size by Application
  6. 8.2.1 North America Tildrakizumab Revenue by Application (2021-2032)
  7. 8.2.2 North America Tildrakizumab Sales by Application (2021-2032)
  8. 8.2.3 North America Tildrakizumab Price by Application (2021-2032)
  9. 8.3 North America Tildrakizumab Market Size by Country
  10. 8.3.1 North America Tildrakizumab Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Tildrakizumab Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Tildrakizumab Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
9 Europe
  1. 9.1 Europe Tildrakizumab Market Size by Type
  2. 9.1.1 Europe Tildrakizumab Revenue by Type (2021-2032)
  3. 9.1.2 Europe Tildrakizumab Sales by Type (2021-2032)
  4. 9.1.3 Europe Tildrakizumab Price by Type (2021-2032)
  5. 9.2 Europe Tildrakizumab Market Size by Application
  6. 9.2.1 Europe Tildrakizumab Revenue by Application (2021-2032)
  7. 9.2.2 Europe Tildrakizumab Sales by Application (2021-2032)
  8. 9.2.3 Europe Tildrakizumab Price by Application (2021-2032)
  9. 9.3 Europe Tildrakizumab Market Size by Country
  10. 9.3.1 Europe Tildrakizumab Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Tildrakizumab Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Tildrakizumab Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Netherlands
10 China
  1. 10.1 China Tildrakizumab Market Size by Type
  2. 10.1.1 China Tildrakizumab Revenue by Type (2021-2032)
  3. 10.1.2 China Tildrakizumab Sales by Type (2021-2032)
  4. 10.1.3 China Tildrakizumab Price by Type (2021-2032)
  5. 10.2 China Tildrakizumab Market Size by Application
  6. 10.2.1 China Tildrakizumab Revenue by Application (2021-2032)
  7. 10.2.2 China Tildrakizumab Sales by Application (2021-2032)
  8. 10.2.3 China Tildrakizumab Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Tildrakizumab Market Size by Type
  2. 11.1.1 Asia Tildrakizumab Revenue by Type (2021-2032)
  3. 11.1.2 Asia Tildrakizumab Sales by Type (2021-2032)
  4. 11.1.3 Asia Tildrakizumab Price by Type (2021-2032)
  5. 11.2 Asia Tildrakizumab Market Size by Application
  6. 11.2.1 Asia Tildrakizumab Revenue by Application (2021-2032)
  7. 11.2.2 Asia Tildrakizumab Sales by Application (2021-2032)
  8. 11.2.3 Asia Tildrakizumab Price by Application (2021-2032)
  9. 11.3 Asia Tildrakizumab Market Size by Country
  10. 11.3.1 Asia Tildrakizumab Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Tildrakizumab Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Tildrakizumab Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Tildrakizumab Market Size by Type
  2. 12.1.1 SAMEA Tildrakizumab Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Tildrakizumab Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Tildrakizumab Price by Type (2021-2032)
  5. 12.2 SAMEA Tildrakizumab Market Size by Application
  6. 12.2.1 SAMEA Tildrakizumab Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Tildrakizumab Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Tildrakizumab Price by Application (2021-2032)
  9. 12.3 SAMEA Tildrakizumab Market Size by Country
  10. 12.3.1 SAMEA Tildrakizumab Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Tildrakizumab Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Tildrakizumab Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Tildrakizumab Value Chain Analysis
  2. 13.1.1 Tildrakizumab Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Tildrakizumab Production Mode & Process
  6. 13.2 Tildrakizumab Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Tildrakizumab Distributors
  9. 13.2.3 Tildrakizumab Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst